SCHEMBL15538420

SCHEMBL15538420

CCC(F)(CC)CN1CCC(COc2ccc(-c3ccc(C(=O)N4CCCC4CO)c(F)c3)cc2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 2/20 0.45
MTOR P42345 2/20 0.45
POLB P06746 1/20 0.41
TRPV1 Q8NER1 2/20 0.40
SPHK2 Q9NRA0 2/20 0.39
SPHK1 Q9NYA1 1/20 0.39
GPR119 Q8TDV5 2/20 0.39
CHRM2 P08172 1/20 0.38
CHRM5 P08912 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
RARA P10276 1/20 0.38
RARB P10826 1/20 0.38
HCRTR1 O43613 1/20 0.38
HCRTR2 O43614 1/20 0.38
PARP10 Q53GL7 2/20 0.38
PARP15 Q460N3 1/20 0.38
SSTR5 P35346 1/20 0.38
KCNH2 Q12809 1/20 0.38
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15538418 1.00 PIK3CA (0.45) PIK3CAMTORPOLBTRPV1SPHK2
SCHEMBL15537661 0.92 PIK3CA (0.44) PIK3CAMTORPOLBTRPV1SPHK2
SCHEMBL15537662 0.92 PIK3CA (0.44) PIK3CAMTORPOLBTRPV1SPHK2
SCHEMBL15539882 0.92 PIK3CA (0.44) PIK3CAMTORPOLBTRPV1SPHK2
SCHEMBL15539132 0.88 SPHK2 (0.49) POLBSPHK2SPHK1
SCHEMBL15539131 0.88 SPHK2 (0.49) POLBSPHK2SPHK1
SCHEMBL16803880 0.88 PARP10 (0.41) SPHK2SPHK1GPR119CHRM2CHRM5
SCHEMBL21534906 0.88 PARP10 (0.41) SPHK2SPHK1GPR119CHRM2CHRM5
SCHEMBL16777195 0.88 PIK3CA (0.42) PIK3CAMTORPOLBTRPV1HCRTR1
SCHEMBL16777192 0.88 PIK3CA (0.42) PIK3CAMTORPOLBTRPV1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US claimed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP claimed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO claimed
EP-2858986-B1 PIPERIDINE DERIVATIVES AS GPR119 AGONISTS CHONG KUN DANG PHARMACEUTICAL CORP (KR) 2019-10-30 EP disclosed
US-9944600-B2 Piperidine derivatives for GPR119 agonist CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2018-04-17 US disclosed
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2015-06-18 US disclosed
EP-2858986-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST Chong Kun Dang Pharmaceutical Corp. (KR) 2015-04-15 EP disclosed
WO-2013187646-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2013-12-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166480-A1 PIPERIDINE DERIVATIVES FOR GPR119 AGONIST GPR119, FFAR2, GPR84 PIK3CA 1887/4885MTOR 2961/4885POLB 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.